Arcutis Biotherapeutics News

Analysts Conflicted on These Healthcare Names: Terns Pharmaceuticals (TERN), Abbott Labs (ABT) and Arcutis Biotherapeutics (ARQT)

TipRanksApr 22 14:50

Analysts Are Bullish on These Healthcare Stocks: GoodRx Holdings (GDRX), Arcutis Biotherapeutics (ARQT)

TipRanksApr 12 18:40

Arcutis Biotherapeutics Analyst Ratings

BenzingaApr 12 18:43

Needham Reiterates Buy on Arcutis Biotherapeutics, Maintains $16 Price Target

BenzingaApr 12 18:44

Analysts Are Bullish on Top Healthcare Stocks: Abivax SA Sponsored ADR (ABVX), Arcutis Biotherapeutics (ARQT)

TipRanksApr 10 14:30

Buy Rating on Arcutis Biotherapeutics Bolstered by Projected Q1 Sales Beat and 2024 Upside Potential

TipRanksApr 10 14:21

Analysts Offer Insights on Healthcare Companies: Marinus (MRNS), Arcutis Biotherapeutics (ARQT) and Axsome Therapeutics (AXSM)

TipRanksMar 27 15:20

Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT), Fulcrum Therapeutics (FULC) and AC Immune SA (ACIU)

TipRanksMar 19 13:50

Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL), Adaptimmune Therapeutics (ADAP) and Arcutis Biotherapeutics (ARQT)

TipRanksMar 13 14:30

Needham Maintains Buy on Arcutis Biotherapeutics, Raises Price Target to $16

BenzingaFeb 28 20:39

Arcutis Biotherapeutics Analyst Ratings

BenzingaFeb 28 20:37

Arcutis Biotherapeutics (ARQT) Gets a Hold From JonesTrading

TipRanksFeb 28 07:25

Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Arcutis Biotherapeutics (ARQT)

TipRanksFeb 28 05:40

Buy Rating Affirmed for Arcutis Biotherapeutics as Zoryve Sales Surge and Market Position Strengthens

TipRanksFeb 28 01:35

Arcutis Biotherapeutics Analyst Ratings

BenzingaFeb 23 23:25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Arcutis Biotherapeutics (ARQT), Walgreens Boots Alliance (WBA) and Twist Bioscience (TWST)

TipRanksFeb 7 23:20

Maintaining a Hold: Arcutis Biotherapeutics' Mixed Q4 Outlook and Zoryve Market Potential

TipRanksJan 30 06:15

Buy Rating for Arcutis Biotherapeutics Amidst Strong Zoryve Foam Launch and Market Penetration Potential

TipRanksJan 24 14:40

Goldman Sachs Reaffirms Their Hold Rating on Arcutis Biotherapeutics (ARQT)

TipRanksJan 23 07:45

Mizuho Upgrades Arcutis to Buy, Cites Zoryve Sales

Seeking AlphaJan 3 23:25